- Home
- APLT vs EHI Comparison
APLT vs EHI Comparison
Compare APLT & EHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- EHI
- Stock Information
- Founded
- APLT 2016
- EHI 2003
- Country
- APLT United States
- EHI United States
- Employees
- APLT N/A
- EHI N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- EHI Investment Managers
- Sector
- APLT Health Care
- EHI Finance
- Exchange
- APLT Nasdaq
- EHI Nasdaq
- Market Cap
- APLT 178.6M
- EHI 194.8M
- IPO Year
- APLT 2019
- EHI N/A
- Fundamental
- Price
- APLT $1.05
- EHI $6.52
- Analyst Decision
- APLT Buy
- EHI
- Analyst Count
- APLT 5
- EHI 0
- Target Price
- APLT $4.13
- EHI N/A
- AVG Volume (30 Days)
- APLT 11.8M
- EHI 44.5K
- Earning Date
- APLT 11-06-2025
- EHI 01-01-0001
- Dividend Yield
- APLT N/A
- EHI 11.54%
- EPS Growth
- APLT N/A
- EHI N/A
- EPS
- APLT N/A
- EHI N/A
- Revenue
- APLT $121,000.00
- EHI N/A
- Revenue This Year
- APLT N/A
- EHI N/A
- Revenue Next Year
- APLT $5,931.24
- EHI N/A
- P/E Ratio
- APLT N/A
- EHI N/A
- Revenue Growth
- APLT N/A
- EHI N/A
- 52 Week Low
- APLT $0.30
- EHI $6.00
- 52 Week High
- APLT $10.62
- EHI $7.75
- Technical
- Relative Strength Index (RSI)
- APLT 66.45
- EHI 42.38
- Support Level
- APLT $0.56
- EHI $6.49
- Resistance Level
- APLT $1.32
- EHI $6.57
- Average True Range (ATR)
- APLT 0.17
- EHI 0.06
- MACD
- APLT 0.05
- EHI -0.01
- Stochastic Oscillator
- APLT 73.60
- EHI 19.05
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About EHI Western Asset Global High Income Fund Inc
Western Asset Global High Inc Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is high current income and total return by investing in a world-wide portfolio of securities. The fund invests in various sectors such as Consumer Discretionary, Energy, Healthcare, Industrials, materials, and others.